Gene

RET - multiple endocrine neoplasia type 2

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 360

RET - multiple endocrine neoplasia type 2



€ 360

RET - multiple endocrine neoplasia type 2

This test is available for the following conditions:

  • Conditions > Hearing impairment > Multiple endocrine neoplasia type 2 (MEN2)
  • Conditions > Endocrine > Multiple endocrine neoplasia type 2 (MEN2)
  • Conditions > Oncogenetics > Multiple endocrine neoplasia type 2 (MEN2)

This product is also part of the following panels:

  • panel paragangliomas / pheochromocytomas (SDHA,SDHB,SDHC,SDHD,SDHAF2,RET,VHL,TMEM127,MAX,FH,MDH2)
  • WES hereditary cancer (99.2% **)
  • WES Mendelian inherited disorders (99.2% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries
Remarks
Analysis of exons 10, 11, 13-16 only. With this test all known mutations are detected and explain 98% of the MEN2 patients.

OMIM: 164761
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 360